Policy | August 18, 2023
India's Medical Value sector projected to reach $ 13 billion by 2026: Dr Mandaviya
Need to harmonize traditional and modern medicine to combat alarming health problems
Need to harmonize traditional and modern medicine to combat alarming health problems
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
LyondellBasell is among the top three global polyolefin manufacturers in terms of capacity and sustainable solutions
DuPont Liveo continued investments demonstrate our long-term commitment to the healthcare industry
AushadhAI is purposefully designed to deliver significant advantages to the pharmaceutical supply chain's key constituents
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
The company has secured 506 marketing approvals for its oncology products across 76 countries.
The company through its IPO will fetch Rs 1475.26 crore - Rs 1550.59 crore at the lower and upper end of the price band.
Subscribe To Our Newsletter & Stay Updated
